4//SEC Filing
Mayer Arie 4
Accession 0001209191-23-022815
CIK 0001176309other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 5:10 PM ET
Size
6.6 KB
Accession
0001209191-23-022815
Insider Transaction Report
Form 4
Mayer Arie
Director
Transactions
- Purchase
Common Stock
2023-04-03$2.22/sh+5,009$11,120→ 23,009 total - Purchase
Common Stock
2023-04-04$2.21/sh+3,800$8,398→ 26,809 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.17 to $2.22, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the above range.
Documents
Issuer
ORAMED PHARMACEUTICALS INC.
CIK 0001176309
Entity typeother
Related Parties
1- filerCIK 0001796583
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 5:10 PM ET
- Size
- 6.6 KB